Related Experiment Videos
K252a induces cell cycle arrest and apoptosis by inhibiting Cdc2 and Cdc25c
L S Chin1, S F Murray, P F Doherty
1Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, USA. lchin@surgery1.umaryland.edu
Abstract:
The indole carbazole K252a has been shown in previous studies to inhibit the platelet-derived growth factor signal transduction pathway in gliomas. Because K252a has nonspecific effects on protein kinase function, we studied its effect on cyclin-dependent kinases (CDK) and cell cycle blockade in glioma cells. K252a blocked T98G cells at the G1/S and G2/M checkpoints. Consistent with cell cycle arrest, K252a was shown to hypophosphorylate Rb, upregulate p21, and decrease Cdc2 and Cdc25c activity. Finally, cell cycle arrest in T98G cells resulted in apoptosis as determined by cell morphology and DNA laddering. K252a is a useful tool for studying the effects of CDK inhibition and cell cycle blockade in tumor cells.
Insights
The indole carbazole K252a inhibits glioma cell growth by blocking the cell cycle at G1/S and G2/M checkpoints, leading to cancer cell death. This compound is valuable for studying cyclin-dependent kinase (CDK) inhibition in tumors.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Platelet-derived growth factor (PDGF) signaling pathway is implicated in glioma progression.
- Indole carbazole K252a is known to inhibit PDGF signaling but has non-specific protein kinase effects.
- Cyclin-dependent kinases (CDKs) regulate cell cycle progression and are often dysregulated in cancer.
Purpose of the Study:
- To investigate the effect of K252a on cyclin-dependent kinases (CDKs) and cell cycle blockade in glioma cells.
- To determine the specific mechanisms by which K252a affects glioma cell proliferation.
- To assess the potential of K252a as a tool for cancer research.
Main Methods:
- T98G glioma cells were treated with K252a.
- Cell cycle progression was analyzed using flow cytometry to identify checkpoint blockade.
- Western blotting was used to assess the levels of cell cycle regulatory proteins (Rb, p21, Cdc2, Cdc25c).
- Apoptosis was evaluated by examining cell morphology and DNA fragmentation.
Main Results:
- K252a induced cell cycle arrest at both the G1/S and G2/M checkpoints in T98G cells.
- Treatment with K252a resulted in hypophosphorylation of Rb, upregulation of p21, and decreased activity of Cdc2 and Cdc25c.
- Cell cycle arrest mediated by K252a led to apoptosis, evidenced by changes in cell morphology and DNA laddering.
Conclusions:
- K252a effectively inhibits glioma cell proliferation by inducing cell cycle arrest and apoptosis.
- The mechanism involves the modulation of key cell cycle regulatory proteins and kinases.
- K252a serves as a valuable pharmacological tool for exploring CDK inhibition and cell cycle blockade strategies in tumor research.